Jeffrey Bozarth
About Jeffrey Bozarth
Jeffrey Bozarth is a Senior Research Scientist II at Bristol-Myers Squibb in New York, with over 30 years of experience in the pharmaceutical industry.
Title at Bristol-Myers Squibb
Jeffrey Bozarth currently holds the title of Senior Research Scientist II at Bristol-Myers Squibb. Based in New York, New York, United States, he has been contributing to the company for over two decades. His tenure at Bristol-Myers Squibb includes previous roles as Senior Research Scientist I from 2003 to 2013 and Research Scientist from 2000 to 2003.
Past Positions in Pharmaceutical Industry
Jeffrey Bozarth has accumulated over 30 years of experience in the pharmaceutical industry, having held multiple senior-level positions. He served as a Senior Staff Scientist at DuPont Pharmaceuticals from 1998 to 2001 and as a Senior Staff Scientist at Merck from 1991 to 1998. Earlier in his career, he worked as a Staff Scientist at DuPont from 1984 to 1991.
Education and Academic Background
Jeffrey Bozarth has earned multiple degrees over his academic career. He studied at Wilmington University twice, completing a program from 2014 to 2017 and another from 2009 to 2013. He also achieved a Bachelor of Arts degree from Immaculata University, where he studied from 1996 to 1998. This diverse educational background has contributed to his extensive expertise in the pharmaceutical field.
Experience at Bristol-Myers Squibb
Bozarth has been with Bristol-Myers Squibb for more than 20 years. During his tenure, he transitioned through several roles, starting as a Research Scientist, moving up to Senior Research Scientist I, and most recently, to Senior Research Scientist II. His long-term association with the company highlights his significant contributions to various research projects over the years.
Expertise in Pharmaceutical Research and Development
With more than three decades of experience, Jeffrey Bozarth has extensive knowledge in pharmaceutical research and development. His role in various capacities at major pharmaceutical companies such as Merck, DuPont, and Bristol-Myers Squibb has enabled him to develop a robust understanding of the industry. His work has primarily been focused on advancing research initiatives within these organizations.